IBD 50's Hims Plummets After Novo Yanks Deal Over 'Deceptive' And 'Illegitimate' Wegovy Knockoffs

investors.com/news/technology/hims-stock-novo-nordisk-ends-deal-wegovy-knockoffs-compounded-semaglutide

Hims stock plummeted Monday after Novo Nordisk ended their collaboration over concerns about Hims' compounded semaglutide.
The post IBD 50's Hims Plummets After Novo Yanks Deal Over 'Deceptive' And 'Illegitimate' Wegovy Knockoffs appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-06-23 12:59:22.
The Entire Business World on a Single Page. Free to Use →